Research article · Feb 2024
Conference abstractPublished 2017
Bioengineered nanomedicines for modulation of intestinal anti-diabetic peptide delivery
University of Porto, Portugal
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Diabetes mellitus is a high prevalence and one of the most severe and lethal diseases in the world with tremendous impact on health worldwide. Anti-diabetic peptides as insulin or GLP-1 are commonly used to treat diabetes in order to give patients a better life condition. However, due to bioavailability problems, their most common route of administration is the subcutaneous route. Invasive delivery route is, still, the most efficient, but less desired by patients. Non-invasive delivery systems have potential to overcome the most pressing problem regarding effective treatment of diabetic patients - therapy compliance, and are thus considered as convenient alternative, but it faces important challenges. Therefore, the nanoencapsulation of antidiabetic peptides into nanoparticles is presented as a good strategy to improve bioavailability. Results: In our research group, we have developed and characterized nanoparticles containing insulin and/or GLP-1 peptides, following their evaluation as medical products to control diabetes upon oral delivery. In particular, we use poly(lactic-co-glycolic acid) (PLGA) modified with chitosan and a cell-penetrating peptide. Afterwards, glucagon like peptide -1 (GLP-1) loaded NPs were encapsulated into a pH-sensitive polymer and loaded with dipeptidyl peptidase-4 (DPP4) inhibitor, using a microfluidics technique. In vivo tests were performed in a rat type 2 diabetes mellitus model by oral gavage, and the blood glucose levels were quantified. The plasmatic insulin levels, as well as the pancreatic insulin content, were also evaluated. Our no-invasive technologies have demonstrated a clear efficacy in lowering the blood glucose levels in diabetic animal models. Not only nanoparticles have demonstrated to be able to cross biological barriers, but also provide sustain release of their peptide payloads. The interaction between the nanoparticles and the intestinal co-culture cells showed that there was a clear increase in the interaction between the modified nanoparticles with the cells. In the in vivo assays, the blood glucose levels decreased after 4 h of the administration of the particles and were kept low thereafter. The insulin levels increased along the time and the insulin pancreatic content was higher in the experimental groups in comparison with the control. No inflammation, cytotoxicity or tissue damage has been associated with chronic use of such nanoparticles, giving promising clinical application in a near future. Conclusions: The developed particles were sensitive to different pH, showing high interaction with intestinal cells. They allowed the dual-delivery of two different drugs in a single formulation. The very low activity of DPP4 enzyme prolonged the GLP-1’s half-life, thus increasing the insulin levels and decreasing the blood glucose levels along the time in vivo. In this presentation, the feasibility of nanomedicines to improve the bioavailability and efficacy of anti-diabetic biopharmaceutical drugs will be demonstrated.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2017
Nanomedicine-Based Combination Anti-Cancer Therapy between Nucleic Acids and Anti-Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti-Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiation
Conference abstract · 8 Jun 2015
Signal peptide-binding drug as a selective CD4 receptor down-modulator with anti-HIV activity
Perspective · 4 Mar 2025
Phytochemical Constituents of Medicinal Plants as Potential Anti-Diabetic Therapeutics: Biochemical and Pharmacological Insights
Research article · 23 Jan 2025
Molecular Docking Studies of Coumarin Derivatives as DPPIV Inhibitors and Anti-Diabetic Agents: Towards Novel Approaches in Drug Discovery
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 12 Jun 2025
Melt-in-Mouth Miracles: A New Era of Drug Delivery with Mouth Dissolving Tablets
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bruno Sarmento”

